- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for Vivus Inc (VVUS)
| Open: | 24.6900 | Day's Range: | 24.2500 - 24.9800 | Volume: | 1,651,836 | Bid: | 24.8700 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 24.5900 | 52wk Range: | 6.1300 - 26.7500 | 1-Yr Rtn: | +181.56% | Ask: | 24.8800 |
Key Statistics for VVUS
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (12/2012) | - |
| Earnings Per Share (USD) (ttm) | -0.5800 |
| Est. EPS (USD) (12/2012) | -0.6780 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 2,481.56 |
| Shares Outstanding (M) | 99.70 |
| Enterprise Value (M USD) (ttm) | 2,148.16 |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | 7.6200 |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 08/01/2012 |
More VVUS Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for VVUS
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for VVUS
VIVUS, Inc. is a biopharmaceutical company developing therapies for obesity, sleep apnea, diabetes and sexual health. The company markets a treatment for erectile dysfunction, and has drugs for obesity and erectile dysfunction in late-stage clinical trials.
| Mark B LoganChairman | Leland F WilsonChief Executive Officer |
| Peter Y TamPresident | Timothy E MorrisSenior VP:Finance/CFO/Secy |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page